Showing results (51-60 of 78) with videos related to
Sort By:
Pageof 8
Experimental Brain Research|October 12, 2024
Cortical drive may facilitate enhanced use of the paretic leg induced by random constraint force to the non-paretic leg during walking in chronic strokeHyosok Lim, Shijun Yan, Weena Dee, et al.The European Journal of Neuroscience|August 15, 2024
Motor interference on lateral pelvis shifting towards the paretic leg during walking and its cortical mechanisms in persons with strokeHyosok Lim, Shijun Yan, Weena Dee, et al.Journal of Neurophysiology|November 20, 2025
Motor variability predicts motor learning of improved trunk postural control through repeated trunk perturbations during walking in children with cerebral palsyShijun Yan, Iram Hameeduddin, Hyosok Lim, et al.Aging Cell|May 5, 2021
Gain of PITRM1 peptidase in cortical neurons affords protection of mitochondrial and synaptic function in an advanced age mouse model of Alzheimer's diseaseFang Du, Qing Yu, Shijun Yan, et al.Journal of Neurophysiology|June 8, 2026
Increasing error at targeted phase of gait facilitates motor adaptation for improving crouch gait in children with cerebral palsyIram Hameeduddin, Shijun Yan, Hyosok Lim, et al.European Journal of Pharmacology|March 2, 2017
Recombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapyYunzhou Wu, Jinjiao He, Jingshu Geng, et al.Virus Research|May 10, 2017
From mouse to pig: Is PRV vaccine safe across two species?Yufang Li, Shijun Yan, Xuefeng Li, et al.Frontiers in Veterinary Science|February 11, 2022
Construction and Immunogenicity of a Recombinant Pseudorabies Virus Variant With TK/gI/gE/11k/28k DeletionShijun Yan, Baicheng Huang, Xiaofei Bai, et al.Technology in Cancer Research & Treatment|July 4, 2013
Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapyYunzhou Wu, Shijun Yan, Zheng Lv, et al.Journal of Medicinal Chemistry|October 7, 2017
Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer's DiseaseJole Fiorito, Jeremie Vendome, Faisal Saeed, et al.Pageof 8